Copyright Reports & Markets. All rights reserved.

Global Pertussis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pertussis Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Azithromycin
      • 1.4.3 Clarithromycin
      • 1.4.4 Erythromycin
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Pertussis Treatment Market Share by Application (2014-2025)
      • 1.5.2 Children
      • 1.5.3 Adults
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pertussis Treatment Market Size
    • 2.2 Pertussis Treatment Growth Trends by Regions
      • 2.2.1 Pertussis Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Pertussis Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pertussis Treatment Market Size by Manufacturers
      • 3.1.1 Global Pertussis Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pertussis Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pertussis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pertussis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Pertussis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Pertussis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pertussis Treatment Market Size by Type (2014-2019)
    • 4.2 Global Pertussis Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pertussis Treatment Market Size (2014-2019)
    • 5.2 Pertussis Treatment Key Players in United States
    • 5.3 United States Pertussis Treatment Market Size by Type
    • 5.4 United States Pertussis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Pertussis Treatment Market Size (2014-2019)
    • 6.2 Pertussis Treatment Key Players in Europe
    • 6.3 Europe Pertussis Treatment Market Size by Type
    • 6.4 Europe Pertussis Treatment Market Size by Application

    7 China

    • 7.1 China Pertussis Treatment Market Size (2014-2019)
    • 7.2 Pertussis Treatment Key Players in China
    • 7.3 China Pertussis Treatment Market Size by Type
    • 7.4 China Pertussis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Pertussis Treatment Market Size (2014-2019)
    • 8.2 Pertussis Treatment Key Players in Japan
    • 8.3 Japan Pertussis Treatment Market Size by Type
    • 8.4 Japan Pertussis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pertussis Treatment Market Size (2014-2019)
    • 9.2 Pertussis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Pertussis Treatment Market Size by Type
    • 9.4 Southeast Asia Pertussis Treatment Market Size by Application

    10 India

    • 10.1 India Pertussis Treatment Market Size (2014-2019)
    • 10.2 Pertussis Treatment Key Players in India
    • 10.3 India Pertussis Treatment Market Size by Type
    • 10.4 India Pertussis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pertussis Treatment Market Size (2014-2019)
    • 11.2 Pertussis Treatment Key Players in Central & South America
    • 11.3 Central & South America Pertussis Treatment Market Size by Type
    • 11.4 Central & South America Pertussis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pertussis Treatment Introduction
      • 12.1.4 Sanofi Revenue in Pertussis Treatment Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 GSK
      • 12.2.1 GSK Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pertussis Treatment Introduction
      • 12.2.4 GSK Revenue in Pertussis Treatment Business (2014-2019)
      • 12.2.5 GSK Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pertussis Treatment Introduction
      • 12.3.4 Merck Revenue in Pertussis Treatment Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Mitsubishi Tanabe Pharma
      • 12.4.1 Mitsubishi Tanabe Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pertussis Treatment Introduction
      • 12.4.4 Mitsubishi Tanabe Pharma Revenue in Pertussis Treatment Business (2014-2019)
      • 12.4.5 Mitsubishi Tanabe Pharma Recent Development
    • 12.5 Astellas Pharma
      • 12.5.1 Astellas Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pertussis Treatment Introduction
      • 12.5.4 Astellas Pharma Revenue in Pertussis Treatment Business (2014-2019)
      • 12.5.5 Astellas Pharma Recent Development
    • 12.6 Shenzhen KangTai Biological Products
      • 12.6.1 Shenzhen KangTai Biological Products Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pertussis Treatment Introduction
      • 12.6.4 Shenzhen KangTai Biological Products Revenue in Pertussis Treatment Business (2014-2019)
      • 12.6.5 Shenzhen KangTai Biological Products Recent Development
    • 12.7 China National Biotec Group
      • 12.7.1 China National Biotec Group Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pertussis Treatment Introduction
      • 12.7.4 China National Biotec Group Revenue in Pertussis Treatment Business (2014-2019)
      • 12.7.5 China National Biotec Group Recent Development
    • 12.8 Changchun Changsheng Life Sciences
      • 12.8.1 Changchun Changsheng Life Sciences Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pertussis Treatment Introduction
      • 12.8.4 Changchun Changsheng Life Sciences Revenue in Pertussis Treatment Business (2014-2019)
      • 12.8.5 Changchun Changsheng Life Sciences Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pertussis is a highly contagious infection of the respiratory tract caused by the bacterium Bordetella pertussis. Pertussis is a slowly progressing disease that is particularly severe among young infants.
      In 2018, the global Pertussis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pertussis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pertussis Treatment development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      GSK
      Merck
      Mitsubishi Tanabe Pharma
      Astellas Pharma
      Shenzhen KangTai Biological Products
      China National Biotec Group
      Changchun Changsheng Life Sciences

      Market segment by Type, the product can be split into
      Azithromycin
      Clarithromycin
      Erythromycin
      Other

      Market segment by Application, split into
      Children
      Adults

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pertussis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Pertussis Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pertussis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now